Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Blobel Friedhelm
Relationship:   President, CEO, Direct...
City:   San Mateo
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   0    

Indirect Shares

   0      
Direct Value   $0    

Indirect Value

   $0      
Total Shares   0      
Total Value   $0      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Sciclone Pharmaceuticals Inc SCLN President, CEO, Direct... 2017-10-13 0 2007-11-20 0    Premium*  
* Premium Members only  

Records found :    173         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-04 4 AS $11.00 $1,100 D/D (100) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-05 4 OE $1.81 $16,652 D/D 9,200 95,984 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-05 4 AS $11.02 $101,388 D/D (9,200) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-20 4 AS $10.38 $128,741 D/D (12,400) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-20 4 OE $1.81 $22,444 D/D 12,400 99,184 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-23 4 OE $1.08 $37,772 D/D 22,807 91,591 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-23 4 AS $10.41 $237,508 D/D (22,807) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-24 4 AS $10.41 $271,986 D/D (25,925) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-24 4 OE $1.08 $27,999 D/D 25,925 91,577 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-25 4 OE $1.08 $9,577 D/D 8,868 95,652 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-25 4 AS $10.54 $93,439 D/D (8,868) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-21 4 OE $1.08 $21,790 D/D 20,176 106,960 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-21 4 AS $9.86 $198,956 D/D (20,176) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-22 4 AS $9.86 $90,714 D/D (9,201) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-22 4 OE $1.08 $9,937 D/D 9,201 95,985 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-23 4 OE $1.08 $10,584 D/D 9,800 96,584 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-23 4 AS $9.76 $95,609 D/D (9,800) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-24 4 AS $9.71 $7,993 D/D (823) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-24 4 OE $1.08 $889 D/D 823 87,607 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-01 4 OE $1.08 $9,936 D/D 9,200 96,726 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-01 4 AS $10.00 $92,010 D/D (9,200) 87,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-02 4 AS $10.01 $44,198 D/D (4,417) 87,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-02 4 OE $1.08 $4,770 D/D 4,417 91,943 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-03 4 OE $1.08 $30,447 D/D 13,296 94,039 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-03 4 AS $10.03 $133,315 D/D (13,296) 87,526 0 -
  173  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us